Petros Pharmaceuticals, Inc.
Petros Pharmaceuticals, Inc. (PTPI) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PTPI · as of Jun 9, 2026
Key Statistics
Explore Petros Pharmaceuticals, Inc. Data
ptpi stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
ptpi competitorsPTPI
CCM
CELU
HEPA
IVF
LIXTStock Performance
Full HistoryAbout Petros Pharmaceuticals, Inc.
Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male health solutions. Their activities include both the commercialization and ongoing development of Stendra, a prescription PDE-…
what is petros pharmaceuticals, inc. · ptpi stock overview · petros pharmaceuticals, inc. company profile · who is petros pharmaceuticals, inc. ceo · ptpi NASDAQ · petros pharmaceuticals, inc. headquarters · petros pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Petros Pharmaceuticals, Inc. (PTPI) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Dec 2, 2020. As of the latest trading session, PTPI stock price is $0.01, with a market capitalization of $171,381. The stock has returned -82.81% over the past 12 months and -31.25% year-to-date.
In fiscal year 2025, Petros Pharmaceuticals, Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Petros Pharmaceuticals, Inc. (PTPI) stock price is $0.01. The stock is traded on NASDAQ under the ticker symbol PTPI. The 52-week range is $0.00 – $0.04.